Milbemycin Oxime/Praziquantel
120 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
120
Total Reports
6
Deaths Reported
500.0%
Death Rate
Active Ingredients
Milbemycin Oxime/Praziquantel
Administration Routes
OralUnknown
Species Affected
Dog 120
Most Affected Breeds
Crossbred Canine/dog 13
Retriever - Labrador 13
Shepherd Dog - German 6
Terrier - Yorkshire 5
Chihuahua 5
Retriever - Golden 5
Shepherd Dog - Australian 4
Maltese 3
Dog (unknown) 3
Beagle 3
Most Reported Reactions
Vomiting 22
Lack of efficacy (endoparasite) - heartworm 17
Diarrhoea 14
Lethargy (see also Central nervous system depression in 'Neurological') 13
Lack of efficacy (endoparasite) - tapeworm 10
Seizure NOS 7
Weight loss 7
Other abnormal test result NOS 6
Lack of efficacy (heartworm) 6
INEFFECTIVE, HEARTWORM LARVAE 5
Reluctant to move 5
Behavioural disorder NOS 4
Outcome Breakdown
Outcome Unknown
47 (39.2%)
Recovered/Normal
44 (36.7%)
Ongoing
22 (18.3%)
Died
3 (2.5%)
Euthanized
3 (2.5%)
Recovered with Sequela
1 (0.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.